MedTrace Logo

MOSES Lithotripsy Technology Applied to Stone Fragmentation During Ureteroscopy

NCT03995758 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2025-07-04

Study results available
· View outcomes & findings →

Summary

To determine if the effects of MOSES laser modulation technology can improve the safety and efficiency to laser fragmentation resulting in decreased total laser time, reduced potential for injury to the patient, and total OR time and utilization.

Conditions

  • Kidney Calculi

Interventions

DEVICE

MOSES

software based modulation of the laser energy delivered from the homium laser source. The software changes the pulsed laser to have two peaks of energy - one to displace water in front of the stone and a second to deliver the laser energy to the stone

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-06
Primary Completion
2021-05-13
Completion
2021-06-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03995758 on ClinicalTrials.gov